MedTrace Logo

Early Detection of Endotheliopathy Post-Transplant

NCT05594251 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2025-01-24

No results posted yet for this study

Summary

The goal of this research study is to learn more about possible risk factors that might be associated with side effects from stem cell transplants in people between the ages of 0 to 26 years old. Specifically, this study is looking at complications that arise from injury to the endothelium, a small layer of cells lining the blood vessels and heart. These complications can affect the heart, lungs, liver, kidneys and intestines and increase risk of severe illness needing care in the intensive care unit.

Conditions

  • Endotheliopathy

Sponsors & Collaborators

  • Le Bonheur Children's Hospital

    collaborator OTHER

  • University of Tennessee

    collaborator OTHER

  • Baylor College of Medicine

    collaborator OTHER

  • St. Jude Children's Research Hospital

    lead OTHER

Principal Investigators

  • Saad Ghafoor, MD · St. Jude Children's Research Hospital

Eligibility

Max Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-28
Primary Completion
2024-05-05
Completion
2024-05-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05594251 on ClinicalTrials.gov